v3 Template
A

Ascenta Capital

Biotechnology / Life Sciences ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$325.0M
Funding Rounds
1
Last Funding
2025-10-09

About Ascenta Capital

Ascenta Capital is dedicated to helping innovative companies grow from their scientific foundations to advance the clinical development of meaningful medicines for patients. They make concentrated investments and provide strategic and operational support to their management teams.

Products & Services

Biotech Investments:Investments ranging from $15-30 million in biotech companies, focusing on translating preclinical science into early human safety and efficiency data (Phase 1 and 2).
Multi-Medicine Platforms:Investment in platforms with multiple medicine opportunities, addressing complex questions of growth, strategy, and value creation for asymmetric upside.

Specialties

Deep Scientific Insight Patient-Centered Approach Strategic Growth Support Phase 1 and 2 Clinical Development Multi-Medicine Platforms

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Inaugural Fund
T: -
FT: Inaugural Fund 		A: 325000000
MR: -
FA: $325 million
FAN: 325000000 		D: 2025-10-09
FD: 2025-10-09 		3 investors
Inaugural Fund Latest
2025-10-09
$325.0M
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

E

Evan Rachlin

Co-Founder and Managing Partner

L

Lorence Kim

Co-Founder and Managing Partner

J

Jeff Chodakewitz

Advisory Partner

M

Michael Rosenblatt

Advisory Partner

P

Paul Deutsch

Advisory Partner

J

John Gutierrez

Vice President

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Ascenta Capital Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Life Sciences
Company Size
~150 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro